Patent intelligence · US
US 2021015826
ANTICANCER PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY
ANTICANCER PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY
Patent details — US 2021015826
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 21, 2021
- Expiration
- Jan 16, 2041
- Applicant
- BERLIN CHEMIE AG [DE]
- CPC classes
- A61K 31/ 517 A I, A61K 31/ 565 A I, A61K 31/ 5377 A I, A61K 39/ 395 A I
Quick answer
US 2021015826 (ANTICANCER PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY) is held by BERLIN CHEMIE AG [DE]. Status: granted. Granted Jan 21, 2021. Expires Jan 16, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BERLIN CHEMIE AG [DE]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 517 A I, A61K 31/ 565 A I, A61K 31/ 5377 A I, A61K 39/ 395 A I, A61K/31517, A61K/315377
More from BERLIN CHEMIE AG [DE]
Related pharmaceutical patents in our USPTO index.
-
WO 2024252263
COMPOSITIONS SOLIDES DE DICHLORHYDRATE D'ÉLACESTRANT, LEURS PROCÉDÉS DE FABRICATION ET MÉTHODES DE TRAITEMENT LES UTILISANT
granted -
WO 2024023766
POLYTHÉRAPIE À BASE D'INHIBITEUR DE P13K
granted -
CA 3259243
POLYTHÉRAPIE ANTICANCÉREUSE COMPRENANT UN INHIBITEUR DE BCL-2
granted -
CA 3259252
POLYTHÉRAPIE ANTICANCÉREUSE COMPRENANT UN INHIBITEUR DE FLT3
granted -
WO 2022029639
FORMULATIONS PHARMACEUTIQUES AMÉLIORÉES COMPRENANT DES INHIBITEURS DE PI3K
granted -
US 2020040086
PHARMACEUTICAL COMBINATIONS COMPRISING AN ANTI-LY75 ANTIBODY
granted -
CA 3102476
ASSOCIATIONS PHARMACEUTIQUES
granted
Frequently asked questions
What is US patent 2021015826?
US 2021015826 (ANTICANCER PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY) is held by BERLIN CHEMIE AG [DE]. Status: granted. Granted Jan 21, 2021. Expires Jan 16, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 2021015826?
BERLIN CHEMIE AG [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does US 2021015826 expire?
Our index shows an expiration date of Jan 16, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.